Approval · Notice of Compliance 21654 · 2018
FERRIPROX: Notice of Compliance 21654
Issued December 21, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21654
- Date
- December 21, 2018
- Company
- Apopharma Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additiona of a manufacturer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FERRIPROX | Not yet assigned | — |
Medicinal ingredients
- DEFERIPRONE 500 MG per TAB
- DEFERIPRONE 1,000 MG per TAB
- DEFERIPRONE 50 G per 500ML